Paul Rothman's Net Worth

$970

Estimate Recalculated Jul 2, 2024 12:27PM EST

Who is Paul Rothman?

Paul Rothman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Merck & Co., Inc., CANCER GENETICS, INC, and LABORATORY CORP OF AMERICA HOLDINGS.

SEC CIK

Paul Rothman's CIK is 0001601332

Past Insider Trading and Trends

2014 was Paul Rothman's most active year for acquiring shares with 2 total transactions. Paul Rothman's most active month to acquire stocks was the month of April. 2022 saw Paul Rothman paying a total of $220,000.00 for 2,363.558 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merck & Co., Inc. (MRK) Snapshot price: $127.535

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Sep 1
Form 3
—
0
—
—
0
No matching records found

CANCER GENETICS, INC (VYNT) Snapshot price: $0.194

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
—
—
5K
May 22
Form 3
—
0
—
—
0
No matching records found

LABCORP HOLDINGS INC. (LH) Snapshot price: $223.385

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
717
—
—
717
Jun 6
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jun 6
Form 3
—
0
—
—
0
No matching records found